Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Polvino William J"'
Autor:
Garcia, José M., Polvino, William J.
Publikováno v:
In Growth Hormone & IGF Research 2009 19(3):267-273
Publikováno v:
In Peptides 2005 26(9):1598-1601
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hill, Albert F.1 HILLSDEN1@AOL.COM, Polvino, William J.2 wpolvino@rejuvenon.com, Wilson, Darcy B.3 dbwilson@tpims.org
Publikováno v:
Journal of Immune Based Therapies & Vaccines. 2005, Vol. 3, p5-12. 12p. 5 Graphs.
Autor:
Gail Murphy, John-Olov Jansson, Claes Ohlsson, Subburaman Mohan, D. Wyss, Johan Svensson, Barry J. Gertz, K. Cerchio, D Krupa, Bengt-Åke Bengtsson, Polvino William J, David J. Baylink
Publikováno v:
Journal of Bone and Mineral Research. 13:1158-1166
The effect of 2 months of treatment with the oral growth hormone (GH) secretagogue MK-677 on markers of bone metabolism was determined in healthy obese male subjects. This was a randomized, double-blind, parallel, placebo-controlled study. Twenty-fou
Autor:
Johan Svensson, D Krupa, Polvino William J, K. Cerchio, Lars Lönn, John-Olov Jansson, Barry J. Gertz, Gail Murphy, B.-Å. Bengtsson, I. Boseaus, D. Wyss, Lars Sjöström
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 83:362-369
Obesity is associated with blunted GH secretion, unfavorable body composition, and increased cardiovascular mortality. The objective of this study was to investigate the effects of oral treatment with the GH secretagogue MK-677 on GH secretion and bo
Autor:
K. Cerchio, Polvino William J, D Krupa, Ora H. Pescovitz, Michael O. Thorner, Barry J. Gertz, Gail Murphy, Emily H. Skiles, Theresa Treep, Suzan S. Pezzoli, Ian Chapman
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 82:3455-3463
To determine the effect of the GH releasing peptide (GHRP)-mimetic, MK-677, on the GH/insulin-like growth factor-I (IGF-I) axis in selected GH-deficient adults, we studied nine severely GH-deficient men [peak serum GH concentration in response to ins
Autor:
Donald B. Kimmel, Henry G. Bone, Angelo A. Licata, Barry J. Gertz, Polvino William J, Robert S. Weinstein, Joseph R. Tucci, Michael R. McClung, Erika Hale, Steven T. Harris, Robert W. Downs
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 82:265-274
Alendronate (ALN) is an aminobisphosphonate employed as an antiresorptive agent in the treatment of osteoporosis. The present study was carried out to determine dose-response relationships, particularly the effects of relatively low doses of ALN, on
Autor:
Timothy Mant, Timothy V Olah, Michael Stepanavage, Johanna Wittreich, Haiyung Cheng, Barry J. Gertz, Mark Edwards, David G. Sciberras, Polvino William J
Publikováno v:
British Journal of Clinical Pharmacology. 43:49-54
Aim We evaluated the pharmacokinetics and pharmacodynamics of oral MK-462 in comparison with oral sumatriptan in healthy male volunteers. Methods Sixteen healthy male volunteers were studied in a rising, single dose, alternating panel design with eig
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.